Topics

Innophos Holdings, Inc. Reports First-Quarter 2019 Results

07:30 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Ongoing Price Increases and Cost Actions Benefit Bottom Line Performance Continued Success with Transition to Lower Cost Value Chain Structure Positions Innophos to Improve Earnings by End of 2019 I...

Other Sources for this Article

Investor Contact
Mark Feuerbach
Innophos
609-366-1204
investor.relations@innophos.com

Media Contact
Ryan Flaim
Sharon Merrill Associates
617-542-5300
iphs@investorrelations.com

NEXT ARTICLE

More From BioPortfolio on "Innophos Holdings, Inc. Reports First-Quarter 2019 Results"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...